Lily Wound provides strategic advice on the most important issues facing emerging and mid-sized life sciences companies today. She has extensive experience representing pharmaceutical, biotechnology, vaccine and other life sciences clients on a wide range of complex commercial, corporate and licensing transactions. She has worked on transactions at all stages of a life sciences product’s life cycle. In addition to life sciences, Ms. Wound has developed an exceptional practice representing domestic and international clients in other industries—such as those in the healthcare, cosmetics, publishing, media, Internet, software and technology industries—in a variety of corporate transactions. Ms. Wound understands the complexities of their businesses and provides solutions-oriented advice on issues that affect them.
Prior to joining WilmerHale, Ms. Wound was a counsel at another law firm in New York where she focused on biotechnology and life sciences matters. During that time she also developed and organized a “Building a Successful Startup” boot camp event for the Cornell Center for Technology Enterprise and Commercialization. Previously, Ms. Wound served as in-house counsel for Hearst Corporation, where she advised on all aspects of Hearst’s businesses relating to traditional media, new media, digital media and healthcare information and technology. Her responsibilities at Hearst included serving as general counsel for an evidence-based medical information and technology company and leading all complex transactions in the newspapers division.
JD, George Washington University Law School
MPH, Boston University
BA, Biochemical Sciences, Harvard University